POLR2H

DNA-directed RNA polymerases I, II, and III subunit RPABC3 · P52434 · POLR2H on Sugi Atlas →

0 patent compounds predicted against POLR2H, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to POLR2H by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection PHASE3UNKNOWN
Intracameral Antibiotic Safety Study PHASE3SUSPENDED
Investigating Datopotamab Deruxtecan Plus Durvalumab Versus Datopotamab Deruxtecan in Patients With PDL1-negative Metastatic Triple-negative Breast Cancer PHASE2RECRUITING
Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma PHASE2RECRUITING
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide PHASE2ACTIVE_NOT_RECRUITING
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome PHASE1COMPLETED
A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors PHASE1COMPLETED
Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas PHASE1COMPLETED
Spironolactone and XPB-1 Integrity in the TFIIH Complex nanENROLLING_BY_INVITATION
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Chromosomal Translocations in Chandigarh Police nanCOMPLETED
DNA Damage & Repair Proteins In Patients With Atherosclerotic Coronary Artery Disease nanCOMPLETED
Gene-expression Profiles in CNS-metastatic Non-small Cell Lung Cancer nanUNKNOWN
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Large-scale COVID-19 Population Screening nanUNKNOWN
Recombinant Interferon Alfa-2b in Treating Patients With Melanoma nanCOMPLETED
A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients nanCOMPLETED
Chronic Cough and CANVAS (Cerebellar Ataxia With Neuropathy and Bilateral Vestibular Areflexia Syndrome) nanCOMPLETED
S9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid Leukemia nanCOMPLETED
CMV Reactivation in Acute Necrotizing Pancreatitis nanCOMPLETED
Choroid Plexus Dysfunction in Neurological Diseases nanRECRUITING
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil nanCOMPLETED
Detection of Viral Particels in Urticaria Patients nanCOMPLETED
Identification and Characterization of Ovarian Cancer and Endometrial Cancer Specific Biomarkers in Vaginal Fluids nanWITHDRAWN
Quantification of Antisense HIV RNA in Patients nanCOMPLETED
Study of Specimens From Young Patients With Neuroblastoma nanCOMPLETED
miRNAs in Critical Limb Ischemia (miRNACLI) nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a POLR2H binder may also engage these)

ProteinNameSimilarity
F2Z4H3 1.000 F2Z4H3 →
Q923G2 1.000 Q923G2 →
Q9M1A8 0.958 Q9M1A8 →
O81097 0.958 O81097 →
Q5R6E0 0.947 Q5R6E0 →
A4FUD3 0.945 A4FUD3 →
Q6DI37 0.945 Q6DI37 →
Q5F3X4 0.943 Q5F3X4 →
Q42450 0.941 Q42450 →
E9Q4Z2 0.941 E9Q4Z2 →
Q28EX9 0.940 Q28EX9 →
Q5HZ97 0.940 Q5HZ97 →
Q9ZT00 0.940 Q9ZT00 →
Q40565 0.940 Q40565 →
A8A8A3 0.940 A8A8A3 →
UBLCP1 Ubiquitin-like domain-containing CTD phosphatase 1 0.940 landscape →
A5AB13 0.940 A5AB13 →
O08810 0.940 O08810 →
Q16864 0.939 Q16864 →
P87252 0.939 P87252 →
Q15W54 0.939 Q15W54 →
EFTUD2 116 kDa U5 small nuclear ribonucleoprotein component 0.939 landscape →
Q5R4C4 0.938 Q5R4C4 →
Q8BGR9 0.938 Q8BGR9 →
Q2KJD7 0.938 Q2KJD7 →
Q40281 0.938 Q40281 →
Q8BPM2 0.938 Q8BPM2 →
Q4FUQ9 0.938 Q4FUQ9 →
Q1C156 0.938 Q1C156 →
Q3YU19 0.938 Q3YU19 →